logo
← ETF skrineri

Amplify Weight Loss Drug & Treatment ETF

THNR

Amplify

Amplify Weight Loss Drug & Treatment ETF (THNR) Akinda fond skriningi (AAOIFI asosida) bo'yicha: Halol emas. Qamrov 74.41%. Quyida: fond beshta standart bo'yicha, fond ma'lumotlari va har bir aktiv o'z hukmi bilan.

Akinda fond skriningi

Akinda fond skriningi (AAOIFI asosida)Halol emasQamrov: 74.41%
  • Halol 51.63%
  • Shubhali 0.00%
  • Halol emas 22.78%
  • Baholanmagan 25.59%

Chiziq kenglikka moslashtirilgan; raqamlar berilganicha ko'rsatilgan va ulushlar yig'indisi har doim ham 100% bo'lmaydi.

Qamrov — fond ulushining biz yaroqli hukmga ega bo'lgan qismi. 95% dan past qamrovda fond faqat ko'rinadigan qism allaqachon 5% chegaradan oshgan bo'lsa baholanadi; aks holda u bu usulda baholanmaydi.

Fond haqida

Emitent
Amplify
Birja (qayerda savdo qilinadi)
AQSh
Domitsil (qayerda ro'yxatdan o'tgan)
AQSh
Hisobot valyutasi
USD
Xarajat koeffitsienti
0.59%
Aktivlar (AUM)
5.97M USD
Aktivlar soni
21 (14 tekshirilgan)
Savat sanasi (provayder)
28 Oct 2026
Savat Akinda tomonidan yuklangan
28 Oct 2026
Hukm yangilangan
3 Nov 2026

Maydon — fond savdo qilinadigan joy; ro'yxat davlati — u ro'yxatdan o'tgan joy. London fondlari Irlandiya yoki Lyuksemburgda ro'yxatdan o'tgan, shuning uchun Buyuk Britaniya ETFlari uchun «Maydon»dan foydalaning.

Beshta standart

StandartHukmHalolHalol emasUlushlar (0–100%)
Akinda fond skriningi (AAOIFI)Halol emas51.63%22.78%
DJIMHalol emas51.63%22.78%
FTSEHalol emas25.68%48.73%
MSCIHalol emas25.68%48.73%
S&PHalol emas51.63%19.48%

Barcha chiziqlar bir xil 0–100% shkalada. Indeks standartlari faqat halol va halol emas ulushini beradi; bo'yalmagan qism shu standart tasniflamaydigan ulush. Qamrov faqat Akinda fond skriningi uchun e'lon qilinadi.

Fond skriningi va to'rtta indeks standarti turli savollarga javob beradi, shuning uchun ular farq qilishi tabiiy. Fond bizning skriningda shubhali, S&P bo'yicha esa halol bo'lishi mumkin; ikkalasi ham to'g'ri.

Fond tarkibi

21 ta aktivdan 1–21, eng kattalari yuqorida · savat sanasi 28 Oct 2026
№AktivUlushAkinda (AAOIFI)DJIMFTSEMSCIS&P
1
NVONovo Nordisk A/S
8.78%HalolHalolHalolHalolHalol
2
AMGNAmgen Inc
6.24%Halol emasHalol emasHalol emasHalol emasHalol emas
3
ROP.SWRoche Holding AG
6.03%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
4
ABBVAbbVie Inc
5.82%HalolHalolHalol emasHalol emasHalol
5
PFEPfizer Inc
5.74%Halol emasHalol emasHalolHalolHalol emas
6
GILDGilead Sciences Inc
5.69%HalolHalolHalol emasHalol emasHalol
7
AZNAstraZeneca PLC
5.68%HalolHalolHalolHalolHalol
8
REGNRegeneron Pharmaceuticals Inc
5.48%HalolHalolHalolHalolHalol
9
4519.TChugai Pharmaceutical Co Ltd
5.24%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
10
MRKMerck & Co Inc
5.08%HalolHalolHalol emasHalol emasHalol
11
1093.HKCSPC Pharmaceutical Group Ltd
4.67%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
12
1801.HKInnovent Biologics Inc
4.46%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
13
VKTXViking Therapeutics Inc
4.01%Halol emasHalol emasHalol emasHalol emasHalol emas
14
ARWRArrowhead Pharmaceuticals Inc
3.70%HalolHalolHalol emasHalol emasHalol
15
ZEAL.COZealand Pharma A/S
3.30%Halol emasHalol emasHalol emasHalol emasBaholanmagan
16
128940.KSHanmi Pharm Co Ltd
2.59%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
17
GPCRStructure Therapeutics Inc
2.32%Halol emasHalol emasHalol emasHalol emasHalol emas
18
1276.HKJiangsu Hengrui Pharmaceuticals Co Ltd
2.16%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
19
KLRAKailera Therapeutics Inc
1.16%Halol emasHalol emasHalol emasHalol emasHalol emas
20
LLYEli Lilly & Co
11.40%HalolHalolHalol emasHalol emasHalol
21
AGPXXInvesco Government & Agency Portfolio 12/31/2031
0.26%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan

"Baholanmagan" — bu kompaniya bo'yicha bizda yaroqli hukm yo'q degani; bunday aktiv hech qachon muvofiq deb hisoblanmaydi.

Akinda fondlar va aksiyalarni qanday tekshiradi